Market open
Enanta/$ENTA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Enanta
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Ticker
$ENTA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
145
Website
Enanta Metrics
BasicAdvanced
$197M
Market cap
-
P/E ratio
-$5.46
EPS
0.60
Beta
-
Dividend rate
Price and volume
Market cap
$197M
Beta
0.6
52-week high
$17.80
52-week low
$8.51
Average daily volume
125K
Financial strength
Current ratio
4.922
Quick ratio
4.649
Long term debt to equity
128.562
Total debt to equity
151.881
Interest coverage (TTM)
-10.67%
Management effectiveness
Return on assets (TTM)
-17.18%
Return on equity (TTM)
-59.64%
Valuation
Price to revenue (TTM)
2.733
Price to book
1.32
Price to tangible book (TTM)
1.32
Price to free cash flow (TTM)
-1.96
Growth
Revenue change (TTM)
-10.71%
Earnings per share change (TTM)
-13.62%
3-year revenue growth (CAGR)
-9.51%
3-year earnings per share growth (CAGR)
9.49%
What the Analysts think about Enanta
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Enanta stock.
Enanta Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Enanta Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Enanta News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enanta stock?
Enanta (ENTA) has a market cap of $197M as of November 22, 2024.
What is the P/E ratio for Enanta stock?
The price to earnings (P/E) ratio for Enanta (ENTA) stock is 0 as of November 22, 2024.
Does Enanta stock pay dividends?
No, Enanta (ENTA) stock does not pay dividends to its shareholders as of November 22, 2024.
When is the next Enanta dividend payment date?
Enanta (ENTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Enanta?
Enanta (ENTA) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.